|
|
||||||||
INVITED REVIEWS |
Department of Clinical Chemistry, University Hospital Ghent, Belgium
Correspondence to: J.R. Delanghe, Laboratory of Clinical Chemistry, Ghent University Hospital (2P8), De Pintelaan 185, B-9000 Ghent, Belgium. Joris.Delanghe{at}ugent.be
Current point-of-care testing (POCT) glucometers are based on various
test principles. Two major method groups dominate the market: glucose
oxidase-based systems and glucose dehydrogenase-based systems using
pyrroloquinoline quinone (GDH-PQQ) as a cofactor. The GDH-PQQ-based
glucometers are replacing the older glucose oxidase-based systems because of
their lower sensitivity for oxygen. On the other hand, the GDH-PQQ test method
results in falsely elevated blood glucose levels in peritoneal dialysis
patients receiving solutions containing icodextrin (e.g., Extraneal;
Baxter, Brussels, Belgium). Icodextrin is metabolized in the systemic
circulation into different glucose polymers, but mainly maltose, which
interferes with the GDH-PQQ-based method. Clinicians should be aware of this
analytical interference. The POCT glucometers based on the GDH-PQQ method
should preferably not be used in this high-risk population and POCT glucose
results inconsistent with clinical suspicion of hypoglycemic coma should be
retested with another testing system.
KEY WORDS: Icodextrin; hyperglycemia; point-of-care testing; maltose; GDH-PQQ.
Received 5 June 2008; accepted 27 January 2009.
This article has been cited by other articles:
![]() |
D. A. Price Case Study: Recurrent Diabetic Ketoacidosis Resulting From Spurious Hypoglycemia: A Deleterious Consequence of Inadequate Detection of Partial Strip Filling by a Glucose Monitoring System Clin. Diabetes, September 1, 2009; 27(4): 164 - 166. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |